1. Home
  2. Apixaban
  Subject:

Apixaban   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Rivaroxaban Dabigatran Atrial fibrillation Anticoagulant Venous thrombosis Edoxaban Thrombin Coagulation Warfarin Heparin Apixaban Paroxysmal attack Catheter ablation Cardiac arrhythmia Radiofrequency ablation Blood plasma Thrombosis Embolism Syndrome Platelet Enzyme inhibitor Tissue factor Protein Thrombocytopenia Enoxaparin sodium
RELATED SUBJECTS:
The publications listed also have these subjects
Rivaroxaban  10 times
Dabigatran  9 times
Atrial fibrillation  7 times
Anticoagulant  7 times
Venous thrombosis  6 times
Thrombin  4 times
Coagulation  4 times
Warfarin  3 times
Heparin  3 times
Enzyme inhibitor  3 times
Embolism  3 times
Vitamin K  2 times
Thrombosis prevention  2 times
Thrombosis  2 times
Partial thromboplastin time  2 times
Hemostasis  2 times
Blood plasma  2 times
Arthroplasty  2 times
Aristotle  2 times
Verapamil  1 time
Transient ischemic attack  1 time
Time  1 time
Thrombus  1 time
Thrombocytopenia  1 time
Syndrome  1 time
Sensitivity analysis  1 time
Red blood cell  1 time
Radiofrequency ablation  1 time
Pulse wave velocity  1 time
Prothrombin time  1 time
Platelet  1 time
Pharmacology  1 time
Peripheral neuropathy  1 time
Percutaneous coronary intervention  1 time
P-glycoprotein  1 time
Osteoporosis  1 time
Osteocalcin  1 time
Norway  1 time
National Health Service  1 time
Myocardial infarction  1 time
Morpholine  1 time
Metabolism  1 time
Melbourne  1 time
Medical ultrasound  1 time
Median nerve  1 time
Mass spectrometry  1 time
MEDLINE  1 time
Intravenous therapy  1 time
Intracranial hemorrhage  1 time
International law  1 time
Intention-to-treat analysis  1 time
Incremental cost-effectiveness ratio  1 time
Immunoglobulin G  1 time
Hemoglobin  1 time
Hematoma  1 time
Gastric bypass surgery  1 time
Gastrectomy  1 time
Embase  1 time
Echocardiography  1 time
D-dimer  1 time
Coronary catheterization  1 time
Coronary artery bypass surgery  1 time
Confidence interval  1 time
Cofactor (biochemistry)  1 time
Clinical trial  1 time
Carpal tunnel  1 time
Caco-2  1 time
Body mass index  1 time
Biomarker  1 time
Australia  1 time
Atherosclerosis  1 time
Artificial intelligence  1 time
Arthritis  1 time
Apoptosis  1 time
Antibody  1 time
Angiography  1 time
Angiogenesis  1 time
Alkaline phosphatase  1 time
ATP-binding cassette transporter  1 time

Publications tagged with this subject: 17

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)

2. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants

3. Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature

4. Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences

5. Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015

6. Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry

7. A morpholine-free process amenable convergent synthesis of apixaban: a potent factor Xa inhibitor

8. The role of new oral anticoagulants in orthopaedics: an update of recent evidence

9. Effects of thromboprophylactic doses of apixaban and rivaroxaban on coagulation and thrombin generation in association with total hip replacement

10. Recurrent atraumatic acute carpal tunnel syndrome due to hematoma caused by distal radioulnar joint arthritis during anticoagulant treatment with apixaban

11. Apixaban for the treatment of saphenous vein graft thrombosis presenting as unstable angina: a case report

12. A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery

13. The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban

14. The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight—a systematic literature review

15. The representativeness of direct oral anticoagulant clinical trials to hospitalized patients with atrial fibrillation

16. Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation

17. In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition


Questions?

Drop us a message.